CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

about

Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells

P2860

Q57753028-599C4C05-B362-4E66-8E95-A8372C67D192

P2860

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

Item

http://www.wikidata.org/entity/Q54212829

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

@en

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

@nl

type

Item

label

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

@en

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

@nl

prefLabel

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

@en

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

@nl

P1476

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

@en

P2093

Ailin Lepletier

http://www.w3.org/2001/XMLSchema#string

Amelia Roman Aguilera

http://www.w3.org/2001/XMLSchema#string

Deborah Barkauskas

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Kazuyoshi Takeda

http://www.w3.org/2001/XMLSchema#string

Kimberley Stannard

http://www.w3.org/2001/XMLSchema#string

Mark J Smyth

http://www.w3.org/2001/XMLSchema#string

Matthias Braun

http://www.w3.org/2001/XMLSchema#string

Michele Wl Teng

http://www.w3.org/2001/XMLSchema#string

Steven W Lane

http://www.w3.org/2001/XMLSchema#string

P2860

The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function

CD155/PVR plays a key role in cell motility during tumor cell invasion and migration

The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens

αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis

The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

RIG-I modulates Src-mediated AKT activation to restrain leukemic stemness.

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.

P304

2613-2625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI98769

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Sébastien Jacquelin

Kyohei Nakamura

I Das

P577

2018-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29757192

http://www.w3.org/2001/XMLSchema#string

P932

5983325

http://www.w3.org/2001/XMLSchema#string

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

about

P2860

P2860

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932